Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Cheng He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8102-8245; OpenAlex author ID A5100330326. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 3 papers · 2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 13

  1. Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer. Co-author DOI 10.1007/s12672-023-00628-z↗
  2. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/curroncol30020126↗
  3. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cance… Co-author DOI 10.1002/cam4.2463↗
  4. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00262-018-2235-8↗
  5. Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients. Co-author DOI 10.1002/ijc.30650↗
  6. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cance… First author DOI 10.1016/j.ejso.2017.07.010↗
  7. Pancreatic cancer: BRCA mutation and personalized treatment. Co-author DOI 10.1586/14737140.2015.1086271↗
  8. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC. Co-author DOI 10.2174/1566524015666150401102218↗
  9. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival. Co-author DOI 10.1016/j.pan.2014.05.797↗
  10. miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins. Co-author DOI 10.2174/1566524014666140228120014↗
  11. Stathmin, interacting with Nf-κB, promotes tumor growth and predicts poor prognosis of pancreatic cancer. Co-author DOI 10.2174/1566524014666140228120913↗
  12. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. First author DOI 10.2174/1566524011313040001↗
  13. microRNA signature for human pancreatic cancer invasion and metastasis. Co-author DOI 10.3892/etm.2012.585↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 13 shared papers, 2012–2023 · strength 0.92
  2. Chen Liu · 6 shared papers, 2015–2023 · strength 0.61
  3. Guopei Luo · 6 shared papers, 2015–2023 · strength 0.52
  4. Quanxing Ni · 3 shared papers, 2015–2023 · strength 0.28
  5. Kaizhou Jin · 4 shared papers, 2015–2019 · strength 0.28
  6. Jin Xu · 5 shared papers, 2012–2017 · strength 0.23
  7. Meng Guo · 3 shared papers, 2015–2017 · strength 0.18
  8. Zhiwen Xiao · 1 shared paper, 2023 · strength 0.17
  9. Weiding Wu · 1 shared paper, 2023 · strength 0.17
  10. Kun Fan · 2 shared papers, 2018–2019 · strength 0.17
  11. Zhiyao Fan · 2 shared papers, 2018–2019 · strength 0.17
  12. Yesiboli Tasiheng · 1 shared paper, 2023 · strength 0.16
  13. Mingjian Ma · 1 shared paper, 2023 · strength 0.16
  14. Xu Wang · 1 shared paper, 2023 · strength 0.16
  15. Yusheng Chen · 1 shared paper, 2023 · strength 0.16
  16. Xuan Lin · 1 shared paper, 2023 · strength 0.16
  17. Zhengjie Dai · 1 shared paper, 2023 · strength 0.16
  18. Xuan Zou · 1 shared paper, 2023 · strength 0.16
  19. Si Shi · 4 shared papers, 2012–2014 · strength 0.15
  20. C. Liu · 3 shared papers, 2013–2015 · strength 0.12
  21. Liang Liu · 2 shared papers, 2014–2017 · strength 0.11
  22. Jiang Long · 2 shared papers, 2012–2014 · strength 0.08
  23. Chen Liu · 2 shared papers, 2012–2014 · strength 0.08
  24. Yiyin Zhang · 1 shared paper, 2018 · strength 0.07
  25. Chao Yang · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.